GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Institute Of Advanced Medicine Holdings Ltd (SGX:9G2) » Definitions » Debt-to-Equity

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Debt-to-Equity : 1.62 (As of Jun. 2022)


View and export this data going back to 2024. Start your Free Trial

What is Singapore Institute Of Advanced Medicine Holdings Debt-to-Equity?

Singapore Institute Of Advanced Medicine Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was S$21.59 Mil. Singapore Institute Of Advanced Medicine Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was S$65.71 Mil. Singapore Institute Of Advanced Medicine Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2022 was S$54.05 Mil. Singapore Institute Of Advanced Medicine Holdings's debt to equity for the quarter that ended in Jun. 2022 was 1.62.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity or its related term are showing as below:

SGX:9G2' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.79   Med: 1.56   Max: 1.62
Current: 0.79

During the past 3 years, the highest Debt-to-Equity Ratio of Singapore Institute Of Advanced Medicine Holdings was 1.62. The lowest was 0.79. And the median was 1.56.

SGX:9G2's Debt-to-Equity is ranked worse than
65.45% of 547 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs SGX:9G2: 0.79

Singapore Institute Of Advanced Medicine Holdings Debt-to-Equity Historical Data

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore Institute Of Advanced Medicine Holdings Debt-to-Equity Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23
Debt-to-Equity
1.56 1.62 0.79

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23
Debt-to-Equity 1.56 1.62 0.79

Competitive Comparison of Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity falls into.


Singapore Institute Of Advanced Medicine Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Singapore Institute Of Advanced Medicine Holdings's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(13.112 + 50.899) / 81.242
=0.79

Singapore Institute Of Advanced Medicine Holdings's Debt to Equity Ratio for the quarter that ended in Jun. 2022 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(21.588 + 65.713) / 54.052
=1.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Singapore Institute Of Advanced Medicine Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Singapore Institute Of Advanced Medicine Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Institute Of Advanced Medicine Holdings Ltd (SGX:9G2) » Definitions » Debt-to-Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Singapore Institute Of Advanced Medicine Holdings Ltd is a healthcare service provider using advanced technology for early and accurate diagnosis, It is engaged in the following business segments Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services. Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services. Maximum revenue is generated from generated from Medical Diagnostics and Treatments.

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Headlines

No Headlines